Two studies by the IDIBAPS IMARD group, listed in the top twelve articles published by the journal Molecular Psychiatry in 2022
The papers, to which Joaquim Raduà and Miquel A. Fullana contributed, were awarded first and third places on the list.
The papers, to which Joaquim Raduà and Miquel A. Fullana contributed, were awarded first and third places on the list.
A study published in the journal World Psychiatry has assessed the impact of mental disorders on physical diseases (such as heart attacks or cancer),1
Combining the data obtained from magnetic resonance imaging and the patient's clinical data could make it possible to estimate the relapse risk after1
The list, published by Clarivate Analytics, identifies the most influential experts, who are among the 1% most highly cited in their speciality in di1
Eliminating childhood adversities such as bullying would avoid one in three cases of schizophrenia, and promoting physical exercise would avoid one i1
Researchers from the Hospital Clínic-IDIBAPS, IDIBELL and CIBERSAM have developed a smartphone app that allows anxiety to be assessed continuously an1
A new international study, in which Hospital Clínic-IDIBAPS researchers took part, shows that people with schizophrenia who are not eligible for clin1
The finding may make it possible to take therapeutic approaches that will increase the success rate of cognitive-behavioral therapy. This is the ther1
The COVID-19 pandemic and lockdown have increased anxiety and depression in many people, but a study has found that eating a balanced diet can help p1
The Marató de TV3 i Catalunya Ràdio telethon will be held on Sunday 19th December to raise money for research into mental disorders. Three experts fr1